21 Oct 2022 , 08:57 AM
Net profit of Emmessar Biotech & Nutrition declined 27.78% to Rs 0.13 crore in the quarter ended September 2022 as against Rs 0.18 crore during the previous quarter ended September 2021. Sales rose 75.00% to Rs 0.07 crore in the quarter ended September 2022 as against Rs 0.04 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 0.07 | 0.04 | 75 |
| OPM % | -300.00 | -575.00 | – |
| PBDT | 0.22 | 0.20 | 10 |
| PBT | 0.20 | 0.18 | 11 |
| NP | 0.13 | 0.18 | -28 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
